Ricolinostat

DB12376InvestigationalSmall molecule

Ricolinostat is under investigation for the treatment of Breast Carcinoma and Metastatic Breast Cancer.

Chemical structure of Ricolinostat
Mechanism
Curator reviewed
Formula / weight
C24H27N5O3 · 433.512 g/mol (avg)
Code names
ACY-1215 · ACY-63

Resolves to

Compound
UNIIWKT909C62BCAS1316214-52-4ChEMBLCHEMBL2364628ChEBI95073PubChem53340666
Structure
InChIKeyQGZYDVAGYRLSKP-UHFFFAOYSA-NSMILESONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C1=CC=CC=C1)C1=CC=CC=C1
Targets
Q9UBN7HDAC6

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
424Drug interactionsStructured to mechanism, not free text
Sign in
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ricolinostat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In